Anti-osteoporotic effects and good biocompatibility of novel bioactive carbon quantum dots in vitro and in ovariectomized mice

Osteoporosis is a prevalent condition among the elderly, and current treatments are limited by their side effects. This study aimed to develop a safe nanocarbon material with anti-osteoporotic properties. A promising candidate, carbon quantum dots (CQDs), was synthesized using a single-step liquid-phase pulse method and characterized by transmission electron microscopy (TEM). To evaluate the biocompatibility and anti-osteoporotic effects of CQDs, they were administered at a dose of 276 μg/mL or a placebo to an osteoporotic mouse model (n = 16) for 3 months. Biocompatibility was assessed through monitoring weight changes, general health, blood tests, and H&E staining of visceral organs. To assess bone quality, imaging, histological analysis, and biomechanical tests were performed. The results showed that CQDs significantly inhibited osteoclastic activity, leading to improved bone mass and mechanical strength without obvious toxicity. These findings suggest CQDs as a promising candidate for safer osteoporosis therapies.